4DX chief executive and founder Andreas Fouras. Picture: Roy VanDerVegt Posted on The Australian, 11 March 2020 An Australian medical technology company is hoping to forge the pathway to a fast-tracked coronavirus diagnosis by reducing the diagnostic time to three hours. 4DX is seeking to partner with an Australian hospital to conduct clinical trials […]
4Dx has appointed E&P (formerly Evans and Partners) and Bell Potter Securities as joint lead managers of its proposed IPO.
4Dx in the news! Check out the latest article on our technology on the Mirage News website: https://www.miragenews.com/second-wind-new-technology-to-help-diagnose-and-manage-respiratory-diseases/
4Dx is continuing to grow! Two new job postings for the Melbourne office were posted today on our Careers page: https://4dx.com/careers
The US Food and Drug Administration (FDA) conducted its administrative acceptance review on 4Dx’s premarket notification (510(k)), and found it contained all of the necessary elements and information needed to proceed with the substantive review.
New news releases from BioMelbourne Network and Biotech Daily, Dec. 10, 2019: (https://biotechdispatch.com.au/news/4dx-raises-15m-in-oversubscribed-capital-raise) ****************** 10 December 2019 Melbourne, Australia: Australian medical technology company 4Dx Limited has raised $15 million in a heavily oversubscribed pre-IPO. The funds raised via the unsecured converting note issue will be used to drive 4Dx’s go-to-market strategy by adding to […]
FOR IMMEDIATE RELEASE As of November 10, 2019, 4Dx is proud to announce that all documents required to support an FDA 510(k) application have been handed over to its agent for electronic submission. After a tremendously successful clinical validation trial, 4Dx founder and CEO, Andreas Fouras, was very happy to announce the trial’s results, which […]
4Dx is pleased to announce the appointment of Dr. Sam Hupert, co-Founder and CEO of Pro Medicus (ASX: PME) to the 4Dx advisory board. Dr. Hupert has made a private investment into 4Dx and agreed to sit on 4Dx’s advisory board, bringing with him more than 37 years of success as a leader in the global […]